相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current and Potential Therapies Targeting Inflammation in NASH
Somaya Albhaisi et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Non-alcoholic fatty liver disease
Elizabeth E. Powell et al.
LANCET (2021)
Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
Carmelo Luci et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
Michelle L. Boland et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)
Hannah K. Drescher et al.
FRONTIERS IN PHYSIOLOGY (2019)
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell et al.
HEPATOLOGY (2019)
Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States
Iliana Doycheva et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Ana L. Gomes et al.
CANCER CELL (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis
Daniel A. Giles et al.
PLOS ONE (2016)
IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Daniel A. Giles et al.
CURRENT DRUG TARGETS (2015)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Obesity and Liver Disease The Epidemic of the Twenty-First Century
Kathleen E. Corey et al.
CLINICS IN LIVER DISEASE (2014)
IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
Isaac T. W. Harley et al.
HEPATOLOGY (2014)
Homeostatic IL-23 receptor signaling limits Th17 response through IL-22-mediated containment of commensal microbiota
Vincent Feng-Sheng Shih et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
Masahiko Matsumoto et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
Fanli Meng et al.
GASTROENTEROLOGY (2012)
Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis
Shu Yan et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Vitamin D deficiency: Correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4
Mona F. Schaalan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition
Michael Charlton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Y. Tang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits et al.
JOURNAL OF IMMUNOLOGY (2009)
Properties and origin of human Th17 cells
Sergio Romagnani et al.
MOLECULAR IMMUNOLOGY (2009)
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis
Marika C. Kullberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6
D Yen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice
N Ghilardi et al.
JOURNAL OF IMMUNOLOGY (2004)
Divergent pro- and Antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation
CA Murphy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R
C Parham et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
